BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ddaysoftware.com//NONSGML DDay.iCal 1.0//EN
BEGIN:VEVENT
DESCRIPTION:Join us at 7:30 PM Central Time on May 23 for a journal club on
  Gene Therapy. Dr. Mark Pennesi discusses the latest developments in the f
 ield through a seminal paper on adenoviral-RPE65 gene therapy for Leber Co
 ngenital Amaurosis that led to the landmark approval by the FDA of gene th
 erapy for this inherited retinal degeneration.  Dr. Pennesi will also be d
 iscussing how gene therapy may be applied to more complex retinal diseases
  that are not due to monogenetic mutations through a clinical trial for ge
 ne therapy targetting the VEGF pathway in age-related macular degeneration
 . PDFs of these papers will be distributed to registered participants for 
 review before the event.  \nModerators: Mrinali Gupta\, MD and Aravinda Ra
 o\, MDASRS Fellowship Training and Education Committee Members\nExpert Fac
 ulty Discussant: Mark Pennesi\, MD\nReviewers: Christopher Aderman\, MD an
 d Thomas Wubben\, MD Co-Chairs\, ASRS Fellow-in-Training Section\n  \n \n 
 \n
DTEND:20180524T013000Z
DTSTAMP:20260405T123320
DTSTART:20180524T003000Z
LOCATION: \,  
SEQUENCE:0
SUMMARY:Journal Club: Gene Therapy - A New Hope
UID:d2baaf11-ea95-424f-ae59-72c4140270af
END:VEVENT
END:VCALENDAR